View : 535 Download: 0

Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction between Esophageal and Gastric Adenocarcinomas

Title
Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction between Esophageal and Gastric Adenocarcinomas
Authors
Suh Y.-S.Na D.Lee J.-S.Chae J.Kim E.Jang G.Lee J.Min J.Ock C.-Y.Kong S.-H.George J.Zhang C.Lee H.-J.Kim J.-I.Kim S.-J.Kim W.H.Lee C.Yang H.-K.
Ewha Authors
나득채
SCOPUS Author ID
나득채scopus
Issue Date
2022
Journal Title
Annals of Surgery
ISSN
0003-4932JCR Link
Citation
Annals of Surgery vol. 275, no. 4, pp. 706 - 717
Keywords
adenocarcinomaclassificationERBB2esophagogastric junctionesophagusgenomeneoplasmproteomesequencingstomachTCGAtranscriptome
Publisher
Lippincott Williams and Wilkins
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
Objective:To investigate the molecular characteristics of AGEJ compared with EAC and gastric adenocarcinoma.Summary of Background Data:Classification of AGEJ based on differential molecular characteristics between EAC and gastric adenocarcinoma has been long-standing controversy but rarely conducted due to anatomical ambiguity and epidemiologic difference.Methods:The molecular classification model with Bayesian compound covariate predictor was developed based on differential mRNA expression of EAC (N = 78) and GCFB (N = 102) from the Cancer Genome Atlas (TCGA) cohort. AGEJ/cardia (N = 48) in TCGA cohort and AGEJ/upper third GC (N = 46 pairs) in Seoul National University cohort were classified into the EAC-like or GCFB-like groups whose genomic, transcriptomic, and proteomic characteristics were compared.Results:AGEJ in both cohorts was similarly classified as EAC-like (31.2%) or GCFB-like (68.8%) based on the 400-gene classifier. The GCFB-like group showed significantly activated phosphoinositide 3-kinase-AKT signaling with decreased expression of ERBB2. The EAC-like group presented significantly different alternative splicing including the skipped exon of RPS24, a significantly higher copy number amplification including ERBB2 amplification, and increased protein expression of ERBB2 and EGFR compared with GCFB-like group. High-throughput 3D drug test using independent cell lines revealed that the EAC-like group showed a significantly better response to lapatinib than the GCFB-like group (P = 0.015).Conclusions:AGEJ was the combined entity of the EAC-like and GCFB-like groups with consistently different molecular characteristics in both Seoul National University and TCGA cohorts. The EAC-like group with a high Bayesian compound covariate predictor score could be effectively targeted by dual inhibition of ERBB2 and EGFR. © 2022 Lippincott Williams and Wilkins. All rights reserved.
DOI
10.1097/SLA.0000000000004303
Appears in Collections:
의료원 > 의료원 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE